H.R. 10522 aims to prohibit the use of live dogs and cats in biomedical research funded by the Department of Health and Human Services. The bill also seeks to enhance accountability regarding federal research spending.
Supporters of H.R. 10522 have praised the bill for promoting animal welfare and ensuring that federal research funding is used ethically. Advocates argue that the bill reflects a growing societal commitment to humane treatment of animals in research settings.
Critics of H.R. 10522 express concerns that the bill may hinder important biomedical research that relies on animal models, potentially delaying advancements in medical science. Some argue that the bill could lead to unintended consequences for research funding and innovation.
The analysis of H.R. 10522, which aims to prohibit the use of live dogs and cats in biomedical research, reveals no direct industry overlaps between the sponsor Nicholas Langworthy's top donor industries and the subject matter of the bill. This indicates a low potential for conflicts of interest arising from financial contributions. The absence of relevant industry connections suggests that the bill may not be influenced by donor interests in this specific area. Therefore, the risk of legislative bias due to donor influence appears minimal. Voters should be aware that while campaign finance can often lead to perceived conflicts, in this case, the data does not support such concerns.
Top industries funding Nicholas Langworthy, ranked by total contributions.
Source: OpenSecrets.org (Center for Responsive Politics)
